↓ Skip to main content

Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients

Overview of attention for article published in Investigational New Drugs, January 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

patent
2 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
44 Mendeley
Title
Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients
Published in
Investigational New Drugs, January 2004
DOI 10.1023/b:drug.0000006173.72210.1c
Pubmed ID
Authors

C. Kloft, E-U. Graefe, P. Tanswell, A. M. Scott, R. Hofheinz, A. Amelsberg, M. O. Karlsson

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 2 5%
United States 1 2%
Unknown 41 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 27%
Student > Ph. D. Student 8 18%
Student > Master 6 14%
Student > Doctoral Student 3 7%
Other 3 7%
Other 5 11%
Unknown 7 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 27%
Medicine and Dentistry 9 20%
Biochemistry, Genetics and Molecular Biology 5 11%
Immunology and Microbiology 4 9%
Chemistry 3 7%
Other 3 7%
Unknown 8 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2024.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Investigational New Drugs
#186
of 1,262 outputs
Outputs of similar age
#16,923
of 143,822 outputs
Outputs of similar age from Investigational New Drugs
#1
of 3 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,262 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,822 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them